Market doesn't like delays (Or Biotech's at the moment - its all battery metals).
NYR have been quite transparent with timelines and there is no material change in todays Qtly.
Fully funded through the trials is fantastic (already known) - but good to reiterate as no cap raise risk holding it back leading into commencement of trials..
As early stage biotechs go, the PCSK-9 trial presents a very attractive risk reward proposition (high probability of favourable trial results and low mkt cap).
Efficacy from mouse models for statins and prior PCSK-9 studies translated very well to human trials, Efficacy is not likely to be an issue at all... So it really is a safety trial with a qn on how big is the reduction in LDL.
- Forums
- ASX - By Stock
- NYR
- Ann: Nyrada Quarterly Activities Report & Appendix 4C
Ann: Nyrada Quarterly Activities Report & Appendix 4C, page-6
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.2¢ |
Change
-0.001(0.96%) |
Mkt cap ! $9.474M |
Open | High | Low | Value | Volume |
5.3¢ | 5.3¢ | 5.2¢ | $2.497K | 47.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 69215 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 81446 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 69215 | 0.051 |
2 | 30000 | 0.050 |
1 | 125483 | 0.045 |
2 | 127272 | 0.044 |
2 | 294464 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 81446 | 1 |
0.056 | 182857 | 2 |
0.057 | 124080 | 2 |
0.060 | 10000 | 1 |
0.061 | 150000 | 1 |
Last trade - 11.35am 09/09/2024 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |